Antihypertensive agents. 3. Synthesis and antihypertensive activity of 3-(4-(p-fluoro-phenyl)-1,2,3,6-tetrahydro-1-pyridyl)-1-(1-(2-hydroxyethyl)-5-methyl-4-pyrazolyl)-1-propanone.
D000433:1-Propanol / Q000138:chemical synthesis / Q000494:pharmacology; D000818:Animals; D000959:Antihypertensive Agents / Q000138:chemical synthesis / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D001921:Brain / Q000187:drug effects; D002415:Cats; D004285:Dogs; D018492:Dopamine Antagonists; D006321:Heart / Q000187:drug effects; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D011720:Pyrazoles / Q000138:chemical synthesis / Q000494:pharmacology*; D011725:Pyridines / Q000138:chemical synthesis / Q000494:pharmacology*; D012702:Serotonin Antagonists; D013057:Spectrum Analysis; D014466:Ultraviolet Rays; D014665:Vasodilator Agents / Q000494:pharmacology
D000959:Antihypertensive Agents; D018492:Dopamine Antagonists; D011720:Pyrazoles; D011725:Pyridines; D012702:Serotonin Antagonists; D014665:Vasodilator Agents; D000433:1-Propanol; D009638:Norepinephrine